Jefferies Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.03M | Sell |
30,000
-289,600
| -91% | -$41.6M | 0.03% | 398 |
|
|
2022
Q2 | $48.9M | Buy |
+319,600
| New | +$48.8M | 0.41% | 39 |
|
|
2022
Q1 | – | Sell |
-19,300
| Closed | -$2.61M | – | 1496 |
|
|
2021
Q4 | $2.61M | Sell |
19,300
-6,100
| -24% | -$721K | 0.02% | 700 |
|
|
2021
Q3 | $2.74M | Buy |
25,400
+25,300
| +25,300% | +$2.89M | 0.02% | 641 |
|
|
2021
Q2 | $11.3K | Buy |
+100
| New | +$11.3K | ﹤0.01% | 1593 |
|
|
2020
Q3 | – | Sell |
-19,700
| Closed | -$1.93K | – | 1328 |
|
|
2020
Q2 | $1.93K | Sell |
19,700
-147,600
| -88% | -$13M | 0.02% | 570 |
|
|
2020
Q1 | $12.7M | Sell |
167,300
-117,300
| -41% | -$9.99M | 0.14% | 120 |
|
|
2019
Q4 | $25.2M | Sell |
284,600
-150,000
| -35% | -$12.5M | 0.2% | 81 |
|
|
2019
Q3 | $32.9M | Sell |
434,600
-156,900
| -27% | -$10.8M | 0.26% | 48 |
|
|
2019
Q2 | $43M | Buy |
591,500
+533,400
| +918% | +$41.9M | 0.31% | 37 |
|
|
2019
Q1 | $4.68M | Sell |
58,100
-59,500
| -51% | -$4.87M | 0.04% | 471 |
|
|
2018
Q4 | $10.8M | Buy |
117,600
+73,800
| +168% | +$6.49M | 0.09% | 179 |
|
|
2018
Q3 | $4.14M | Buy |
43,800
+7,100
| +19% | +$673K | 0.03% | 618 |
|
|
2018
Q2 | $3.4M | Sell |
36,700
-177,000
| -83% | -$17.3M | 0.02% | 644 |
|
|
2018
Q1 | $20.2M | Buy |
213,700
+95,600
| +81% | +$10.5M | 0.11% | 116 |
|
|
2017
Q4 | $11.4M | Sell |
118,100
-71,500
| -38% | -$6.74M | 0.05% | 268 |
|
|
2017
Q3 | $16.8M | Buy |
189,600
+79,300
| +72% | +$6.04M | 0.11% | 159 |
|
|
2017
Q2 | $8M | Sell |
110,300
-599,400
| -84% | -$40.3M | 0.05% | 340 |
|
|
2017
Q1 | $46.2M | Buy |
709,700
+515,800
| +266% | +$32.4M | 0.34% | 37 |
|
|
2016
Q4 | $12.1M | Buy |
193,900
+113,100
| +140% | +$6.9M | 0.07% | 280 |
|
|
2016
Q3 | $5.1M | Buy |
80,800
+52,900
| +190% | +$3.42M | 0.03% | 521 |
|
|
2016
Q2 | $1.73M | Sell |
27,900
-101,700
| -78% | -$6.2M | 0.01% | 928 |
|
|
2016
Q1 | $7.4M | Sell |
129,600
-331,800
| -72% | -$18.5M | 0.04% | 340 |
|
|
2015
Q4 | $27.3M | Buy |
461,400
+44,500
| +11% | +$2.56M | 0.16% | 115 |
|
|
2015
Q3 | $22.7M | Sell |
416,900
-65,900
| -14% | -$4.29M | 0.13% | 127 |
|
|
2015
Q2 | $32.4M | Sell |
482,800
-89,900
| -16% | -$5.87M | 0.17% | 100 |
|
|
2015
Q1 | $33.5M | Sell |
572,700
-787,300
| -58% | -$47.6M | 0.19% | 72 |
|
|
2014
Q4 | $89M | Buy |
1,360,000
+834,200
| +159% | +$52.6M | 0.52% | 29 |
|
|
2014
Q3 | $30.4M | Buy |
525,800
+515,800
| +5,158% | +$28.6M | 0.21% | 91 |
|
|
2014
Q2 | $564K | Sell |
10,000
-170,000
| -94% | -$8.92M | ﹤0.01% | 1169 |
|
|
2014
Q1 | $9.25M | Sell |
180,000
-44,100
| -20% | -$2.23M | 0.09% | 178 |
|
|
2013
Q4 | $11.8M | Buy |
+224,100
| New | +$11M | 0.08% | 145 |
|
|
2013
Q3 | – | Sell |
-99,500
| Closed | -$4.11M | – | 1895 |
|
|
2013
Q2 | $4.11M | Buy |
+99,500
| New | +$4.35M | 0.04% | 293 |
|
Other funds holding ABBV
Jefferies Group's ABBV Position: Q3 2022 in Review
Jefferies Group increased its AbbVie (ABBV) stake by 32% in Q3 2022, buying an estimated $2.44M and bringing the position to 70,155 shares worth $9.42M. The position accounts for 0.08% of the portfolio, ranked #199.
Jefferies Group first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $18.1M in Q2 2018. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Jefferies Group held 70,155 shares of AbbVie worth $9.42M as of Q3 2022.
- Jefferies Group bought 16,993 AbbVie shares in Q3 2022, an estimated $2.44M.
- AbbVie made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #199 holding.
- Jefferies Group first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's AbbVie position peaked at $18.1M in Q2 2018.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.